Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline
Menalled, L.B. and Patry, M. and Ragland, N. and Lowden, Philip A.S. and Goodman, J. and Minnich, J. and Zahasky, B. and Park, L. and Leeds, J. and Howland, D. and Signer, E. and Tobin, A.J. and Brunner, D. (2010) Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline. PLoS One 5 (3), ISSN 1932-6203.
|
Text
1027.pdf - Published Version of Record Available under License Creative Commons Attribution. Download (1MB) | Preview |
Abstract
Previous studies of the effects of coenzyme Q10 and minocycline on mouse models of Huntington’s disease have produced conflicting results regarding their efficacy in behavioral tests. Using our recently published best practices for husbandry and testing for mouse models of Huntington’s disease, we report that neither coenzyme Q10 nor minocycline had significant beneficial effects on measures of motor function, general health (open field, rotarod, grip strength, rearing-climbing, body weight and survival) in the R6/2 mouse model. The higher doses of minocycline, on the contrary, reduced survival. We were thus unable to confirm the previously reported benefits for these two drugs, and we discuss potential reasons for these discrepancies, such as the effects of husbandry and nutrition.
Metadata
Item Type: | Article |
---|---|
School: | Birkbeck Faculties and Schools > Faculty of Science > School of Natural Sciences |
Research Centres and Institutes: | Structural Molecular Biology, Institute of (ISMB) |
Depositing User: | Administrator |
Date Deposited: | 04 Aug 2010 14:09 |
Last Modified: | 02 Aug 2023 16:49 |
URI: | https://eprints.bbk.ac.uk/id/eprint/1027 |
Statistics
Additional statistics are available via IRStats2.